LD-2 disclosure · 3rd Quarter - Termination
AMICUS THERAPEUTICS, INC.
Coverage · No income or expenses were reported on this filing.
Client
- Name
- AMICUS THERAPEUTICS, INC.
- Description
- a global, patient-dedicated biotechnology company focused on discovering, developing and d
- Location
- New Jersey · United States of America
Registrant
- Description
- Government Consulting
- Location
- Purcellville, Virginia, United States of America
Lobbying activities
3 issuesHealth Issues
Medicare and Medicaid rare diseases
LobbyistsMICHAEL J EGING
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Medicare and Medicaid rare diseases
LobbyistsMICHAEL J EGING
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medical/Disease Research/Clinical Labs
Medicare and Medicaid rare diseases
LobbyistsMICHAEL J EGING
TargetedSENATE · HOUSE OF REPRESENTATIVES